Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Stockholders Approve Name Change to OncoGenex Pharmaceuticals, Inc., and One-for-Eighteen Reverse Stock Split Sonus Pharmaceuticals Expects to Complete Arrangement With ...
-
BOTHELL, Wash., Aug. 18, 2008 (GLOBE NEWSWIRE) -- Sonus Pharmaceuticals, Inc. (Nasdaq:SNUS) announced today that its Board of Directors has set August 19, 2008, as the date of its Special Meeting of...
-
BOTHELL, Wash., Aug. 7, 2008 (PRIME NEWSWIRE) -- Sonus Pharmaceuticals, Inc. (Nasdaq:SNUS) announced today that it has signed an exclusive in-licensing agreement with Bayer HealthCare LLC for...
-
Combined Company Will Have Three Oncology Products in Clinic Lead Candidate Targets Hormone Refractory Prostate and Non-Small Cell Lung Cancers Conference...
-
BOTHELL, Wash., May 9, 2008 (PRIME NEWSWIRE) -- Sonus Pharmaceuticals, Inc. (Nasdaq:SNUS) today announced that it has received a determination letter from The Nasdaq Stock Market ("Nasdaq") dated May...
-
Company Focuses on SN2310 and External Initiatives; Ends Internal Discovery Effort Cash Burn Further Reduced BOTHELL, Wash., March 25, 2008...
-
Company Continues Efforts to Maximize Shareholder Value Conference Call to be Held Today at 1:30 P.M. PT/4:30 P.M. ET BOTHELL, Wash., March 5, 2008 (PRIME NEWSWIRE) -- Sonus...
-
BOTHELL, Wash., Feb. 20, 2008 (PRIME NEWSWIRE) -- Sonus Pharmaceuticals, Inc. (Nasdaq:SNUS), an oncology drug development company, today announced that it will release financial results for the fourth...
-
Company Provides Update on Ongoing Operations and Efforts to Maximize Shareholder Value $30 Million in Cash Expected at December 31, 2007 Conference Call...
-
BOTHELL, Wash., Nov. 7, 2007 (PRIME NEWSWIRE) -- Sonus Pharmaceuticals, Inc. (Nasdaq:SNUS) today announced that it has received a notice from The Nasdaq Stock Market ("Nasdaq") dated November 5, 2007,...